James D. Otvos, PhD

Dr. Otvos received a Ph.D. in comparative biochemistry from the University of California-Berkeley and postdoctoral training in molecular biophysics at Yale University.  He spent the following 20 years in academia, first on the chemistry faculty of the University of Wisconsin-Milwaukee and then as Professor of Biochemistry at North Carolina State University during which time he developed new technology for measuring lipoprotein particles using nuclear magnetic resonance (NMR) spectroscopy. He then founded LipoScience, Inc.

Howard David Engler, PhD, D(ABMM)

Dr Engler is a diplomate of the American Board of Medical and Public Health Microbiology. He earned his PhD in medical microbiology and immunology from The Ohio State University. He completed postdoctoral fellowship training in medical and public health microbiology at the Mt. Sinai Medical Center in New York.

Horacio G. Vall, PhD

Dr Vall is a board-certified clinical laboratory scientist (CLS) and holds a Qualification in Cytometry (QCYM) certification from the American Society for Clinical Pathology. He received his doctorate at the National University of Rosario, Argentina.

Horacio G. Vall, PhD

Dr Vall is a board-certified clinical laboratory scientist (CLS) and holds a Qualification in Cytometry (QCYM) certification from the American Society for Clinical Pathology. He received his doctorate at the National University of Rosario, Argentina.

Henry Y. Dong, MD, PhD

Dr Dong is board certified in anatomic pathology and hematopathology. He earned his medical degree from Beijing Medical University and his PhD in molecular cell biology from the Albert Einstein College of Medicine. He was a postdoctoral research fellow at the Dana Farber Cancer Institute. Dr Dong completed his pathology residency at Massachusetts General Hospital followed by a Vickery fellowship in surgical pathology and a James Homer fellowship in hematopathology.

Henry Y. Dong, MD, PhD

Dr Dong is board certified in anatomic pathology and hematopathology. He earned his medical degree from Beijing Medical University and his PhD in molecular cell biology from the Albert Einstein College of Medicine. He was a postdoctoral research fellow at the Dana Farber Cancer Institute. Dr Dong completed his pathology residency at Massachusetts General Hospital followed by a Vickery fellowship in surgical pathology and a James Homer fellowship in hematopathology.

Hema Ketha, PhD

Dr. Ketha graduated from the University of Delhi, India in 2000. She received her master in science with an emphasis in organic chemistry in 2005 from University of Delhi and completed her PhD in pharmaceutical chemistry from University of Florida in Gainesville in 2010. As a part of post-doctoral training, Dr Ketha completed three years of clinical laboratory research and two years of clinical chemistry fellowship from the Mayo Clinic in Rochester, Minnesota in 2015.

Hema Ketha, PhD

Dr Ketha graduated from the University of Delhi, India in 2000. She received her master in science with an emphasis in organic chemistry in 2005 from University of Delhi and completed her PhD in pharmaceutical chemistry from University of Florida in Gainesville in 2010. As a part of post-doctoral training, Dr Ketha completed three years of clinical laboratory research and two years of clinical chemistry fellowship from the Mayo Clinic in Rochester, Minnesota in 2015.

Gregory Clark Janis

Mr Janis earned undergraduate degrees in biochemistry and chemistry at Virginia Tech and an MS in toxicology at University of North Carolina. He has 2 decades of experience developing techniques for the analysis of pharmaceuticals and drugs of abuse. Current interests include high-throughput mass spectrometry screening techniques, as well as the identification and analysis of new and emerging drugs of abuse. He is a member of the American Society for Mass Spectrometry and the Society for Forensic Toxicologists.

Publications